Corient Private Wealth’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.59M Sell
34,597
-56,936
-62% -$4.06M ﹤0.01% 1127
2025
Q4
$3.97M Buy
91,533
+60,632
+196% +$3.57M ﹤0.01% 1171
2025
Q3
$1.81M Buy
30,901
+954
+3% +$55.6K ﹤0.01% 1114
2025
Q2
$1.74M Sell
29,947
-2,401
-7% -$136K ﹤0.01% 1093
2025
Q1
$1.61M Sell
32,348
-906
-3% -$46.4K ﹤0.01% 1064
2024
Q4
$1.49M Buy
33,254
+6,027
+22% +$286K ﹤0.01% 1125
2024
Q3
$1.31M Sell
27,227
-3,151
-10% -$152K ﹤0.01% 1280
2024
Q2
$1.55M Buy
30,378
+17,662
+139% +$967K ﹤0.01% 1146
2024
Q1
$691K Sell
12,716
-15,094
-54% -$787K ﹤0.01% 1469
2023
Q4
$1.57M Buy
27,810
+2,229
+9% +$126K ﹤0.01% 1114
2023
Q3
$1.58M Buy
25,581
+7,946
+45% +$503K ﹤0.01% 1004
2023
Q2
$1.04M Sell
17,635
-4,693
-21% -$299K ﹤0.01% 1137
2023
Q1
$1.65M Buy
22,328
+4,164
+23% +$321K ﹤0.01% 910
2022
Q4
$1.33M Buy
+18,164
New +$1.44M ﹤0.01% 827

Other funds holding NTR

Corient Private Wealth's NTR Position: Q1 2026 in Review

Corient Private Wealth reduced its Nutrien (NTR) stake by 62% in Q1 2026, selling an estimated $4.06M and leaving 34,597 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Corient Private Wealth first reported a position in NTR in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.97M in Q4 2025. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Corient Private Wealth held 34,597 shares of Nutrien worth $2.59M as of Q1 2026.
  • Corient Private Wealth sold 56,936 Nutrien shares in Q1 2026, an estimated $4.06M.
  • Nutrien made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1127 holding.
  • Corient Private Wealth first reported a position in Nutrien in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Nutrien position peaked at $3.97M in Q4 2025.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.